Simon Tate

Insider Reports History

Entity
Individual
Location
C/O Eliem Therapeutics, Inc., 23515 Ne Novelty Hill Rd, Ste B221 #125, Redmond, WA
Signature
/s/ William Cowles, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simon Tate:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. Director Stock Option (Right To Buy) 10K Jun 26, 2024 Direct

Insider Reports Filed by Simon Tate

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELYM Eliem Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 28, 2024 Director
ELYM Eliem Therapeutics, Inc. May 18, 2023 1 $0 4 May 22, 2023 Director
ELYM Eliem Therapeutics, Inc. May 19, 2022 1 $0 4 Jun 1, 2022 Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 1 $0 4 Aug 11, 2021 Director
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 Director